A drug called levothyroxine, the second-most-commonly prescribed medication among older U.S. adults, has been linked to a higher risk of bone loss in a new study. Levothyroxine is prescribed to ...
according to the latest findings to show that the rapid rebound of bone loss after denosumab discontinuation is not easily prevented with other therapies — even bisphosphonates. “When ...
A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds. Levothyroxine — marketed under brand names such as Synthroid — is the ...